Citi Provides Color on Thomson Reuters, Hold

Citi provided color on Thomson Reuters TRI as the company announced its plans to sell its Healthcare business by the end of this year. In a research report published today, Citi states, "Thomson Reuters announced that it intends to divest its Healthcare business from its "Health & Science" division by the end of this year. CEO, Tom Glocer believes they can achieve better "all-in return" for shareholders by divesting the business and investing in their core franchises, where they see "significant opportunities for future growth and profitability"." At the moment, Citi has a Hold rating and a price target of $40 on the company's stock. On Monday, Thomson Reuters lost 0.61% of its value to close the day at $37.60.